$AAQL
Antiaging Quantum Living Inc.

2023 Q4 Form 10-Q Financial Statement

#000149315223040768 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q1
Revenue $6.299K
YoY Change 57.48%
Cost Of Revenue $760.00
YoY Change
Gross Profit $5.539K
YoY Change 38.48%
Gross Profit Margin 87.93%
Selling, General & Admin $102.6K $24.38K
YoY Change 852.77% 224.2%
% of Gross Profit 1852.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00 -$80.00
YoY Change 0.0% -200.0%
% of Gross Profit 1.44%
Operating Expenses $102.6K $24.38K
YoY Change 852.77% 224.18%
Operating Profit -$97.09K -$24.38K
YoY Change 1333.74% 1503.82%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.00
YoY Change
Pretax Income -$97.09K -$24.38K
YoY Change 1333.7% 1503.82%
Income Tax
% Of Pretax Income
Net Earnings -$97.09K -$24.38K
YoY Change 1333.7% 1503.82%
Net Earnings / Revenue -1541.36%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.7K $55.03K
YoY Change 13861.11% 4133.08%
Cash & Equivalents $125.6K $55.03K $354.00
Short-Term Investments
Other Short-Term Assets $57.65K $27.55K
YoY Change 11203.92%
Inventory
Prepaid Expenses
Receivables
Other Receivables $27.55K $27.55K
Total Short-Term Assets $183.3K $82.59K $354.00
YoY Change 12927.58% 6248.04% -97.52%
LONG-TERM ASSETS
Property, Plant & Equipment $155.3K $383.00 $540.00
YoY Change 24985.14% -45.05% -36.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $33.13K
YoY Change
Total Long-Term Assets $815.8K $383.00 $540.00
YoY Change 131692.08% -45.05% -36.77%
TOTAL ASSETS
Total Short-Term Assets $183.3K $82.59K $354.00
Total Long-Term Assets $815.8K $383.00 $540.00
Total Assets $999.1K $82.97K $894.00
YoY Change 49213.47% 4052.7% -94.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.00K $10.92K $901.00
YoY Change 3066.67%
Accrued Expenses $317.3K $901.00
YoY Change
Deferred Revenue $2.800K
YoY Change -50.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $371.4K $115.3K
YoY Change 386.72% 62.68%
Total Short-Term Liabilities $726.2K $139.9K $87.00K
YoY Change 797.6% 88.78% 34.68%
LONG-TERM LIABILITIES
Long-Term Debt $427.7K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $427.7K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $726.2K $139.9K $87.00K
Total Long-Term Liabilities $427.7K $0.00
Total Liabilities $1.154M $139.9K $87.00K
YoY Change 1326.24% 88.78% 34.68%
SHAREHOLDERS EQUITY
Retained Earnings -$427.5K -$330.4K -$276.3K
YoY Change 58.87% 25.96% 15.28%
Common Stock $30.00K $30.00K $30.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$154.7K -$56.91K -$86.11K
YoY Change
Total Liabilities & Shareholders Equity $999.1K $82.97K $894.00
YoY Change 49213.47% 4052.7% -94.09%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q1
OPERATING ACTIVITIES
Net Income -$97.09K -$24.38K
YoY Change 1333.7% 1503.82%
Depreciation, Depletion And Amortization $80.00 -$80.00
YoY Change 0.0% -200.0%
Cash From Operating Activities -$453.7K -$29.99K
YoY Change 7723.1% 209.81%
INVESTING ACTIVITIES
Capital Expenditures $153.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$153.4K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 677.1K 98.04K
YoY Change 12438.33% 890.3%
NET CHANGE
Cash From Operating Activities -453.7K -29.99K
Cash From Investing Activities -153.4K
Cash From Financing Activities 677.1K 98.04K
Net Change In Cash 69.93K 68.05K
YoY Change -17582.5% 30831.82%
FREE CASH FLOW
Cash From Operating Activities -$453.7K -$29.99K
Capital Expenditures $153.4K
Free Cash Flow -$607.1K
YoY Change 10367.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001672571
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
ACHN Related Party Debt Forgiven As Additional Paidin Capital
RelatedPartyDebtForgivenAsAdditionalPaidinCapital
usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56157
dei Entity Registrant Name
EntityRegistrantName
Antiaging Quantum Living Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2643986
dei Entity Address Address Line1
EntityAddressAddressLine1
133-27 39th Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
Ths #PH2A
dei Entity Address City Or Town
EntityAddressCityOrTown
Flushing
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11354
dei City Area Code
CityAreaCode
(929)
dei Local Phone Number
LocalPhoneNumber
527-5382
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29995000 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55034 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
354 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
27554 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
82588 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
354 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
383 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
540 usd
CY2023Q3 us-gaap Assets
Assets
82971 usd
CY2023Q1 us-gaap Assets
Assets
894 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10918 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
901 usd
CY2023Q3 us-gaap Other Loans Payable
OtherLoansPayable
115335 usd
CY2023Q1 us-gaap Other Loans Payable
OtherLoansPayable
83300 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2800 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
139883 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
87001 usd
CY2023Q3 us-gaap Liabilities
Liabilities
139883 usd
CY2023Q1 us-gaap Liabilities
Liabilities
87001 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
243530 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-330437 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-276332 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-56912 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-86107 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82971 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
894 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1200 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8400 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24378 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7520 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55305 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31025 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
24378 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7520 usd
us-gaap Operating Expenses
OperatingExpenses
55305 usd
us-gaap Operating Expenses
OperatingExpenses
31025 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24378 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1520 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-54105 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22625 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24378 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1520 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54105 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22625 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24378 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1520 usd
us-gaap Net Income Loss
NetIncomeLoss
-54105 usd
us-gaap Net Income Loss
NetIncomeLoss
-22625 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29995000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29995000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29995000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29995000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-86107 usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
83300 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29727 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-32534 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24378 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-56912 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-70582 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1520 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-72102 usd
us-gaap Net Income Loss
NetIncomeLoss
-54105 usd
us-gaap Net Income Loss
NetIncomeLoss
-22625 usd
us-gaap Depreciation
Depreciation
157 usd
us-gaap Depreciation
Depreciation
157 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
27554 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10017 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
13630 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2800 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2400 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60655 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24868 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
115335 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
115335 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11900 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
54680 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12968 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
354 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14269 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
55034 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1301 usd
ACHN Related Party Debt Forgiven As Additional Paidin Capital
RelatedPartyDebtForgivenAsAdditionalPaidinCapital
83300 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-29
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zAA6GmQchp27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zr3mTOC8FhI6">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-330437 usd
CY2023Q3 ACHN Working Capital
WorkingCapital
-57295 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2800 usd
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Net operation losses (“NOLs”) can be carried forever based on the 2017 Tax Cuts and Jobs Act
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
80362 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
69000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares

Files In Submission

Name View Source Status
0001493152-23-040768-index-headers.html Edgar Link pending
0001493152-23-040768-index.html Edgar Link pending
0001493152-23-040768.txt Edgar Link pending
0001493152-23-040768-xbrl.zip Edgar Link pending
achn-20230930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
achn-20230930_pre.xml Edgar Link unprocessable
achn-20230930_cal.xml Edgar Link unprocessable
achn-20230930_def.xml Edgar Link unprocessable
achn-20230930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending